B-lymphoid transcriptional programme as a barrier against malignant transformati...
Prof Markus Müschen - City of Hope Comprehensive Cancer Center, Los Angeles, USA
B-lymphoid transcriptional programme as a barrier against malignant transformation in acute lymphoblastic leukaemia ( Prof Markus Müschen - City of Hope Comprehensive Cancer Center, Los Angeles, USA )
24 May 2019
Emerging role of radioembolization for hepatocellular carcinoma
Prof Riad Salem - Northwestern University, Chicago, USA
Emerging role of radioembolization for hepatocellular carcinoma ( Prof Riad Salem - Northwestern University, Chicago, USA )
8 May 2019
Advanced HCC: New systemic treatment options
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Advanced HCC: New systemic treatment options ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019
Surgical management of pancreatic cancer
Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia
Surgical management of pancreatic cancer ( Prof Ibrahim Al-Sheneber - Saudi Cancer Foundation, Khobar, Saudi Arabia )
8 May 2019
Highlights from IGILUC 2019
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from IGILUC 2019 ( Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
8 May 2019
PARP inhibitors and their side effects in solid tumour therapy
Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )
8 May 2019
KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases
Dr Marina Garassino - National Tumor Institute, Milan, Italy
KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases ( Dr Marina Garassino - National Tumor Institute, Milan, Italy )
15 Apr 2019
Immune checkpoint inhibitor combination efficacious for patients with high-grade...
Prof Sandip Patel - UC San Diego, San Diego, USA
Immune checkpoint inhibitor combination efficacious for patients with high-grade neuroendocrine carcinoma ( Prof Sandip Patel - UC San Diego, San Diego, USA )
11 Apr 2019
Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brou...
Prof Josep Llovet, Dr Richard Finn
Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brought to you by Oncology Knowledge into Practice ( Prof Josep Llovet, Dr Richard Finn )
25 Feb 2019
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic pr...
Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic profiling of tissue and circulating tumour DNA ( Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah )
25 Oct 2018
Two important pancreatic studies: PRODIGE 24 and PREOPANC
Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA
Two important pancreatic studies: PRODIGE 24 and PREOPANC ( Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Aug 2018
MyPathway study: a novel precision oncology multiple basket trial
Dr Mary S. Beattie - Genentech, USA
MyPathway study: a novel precision oncology multiple basket trial ( Dr Mary S. Beattie - Genentech, USA )
6 Jul 2018